Prostate cancer diagnostics: Innovative imaging in case of multiple negative biopsies

World Journal of Urology

Volumn 29, Issue 5, 2011, Pages 607-614

  Loch, Tillmann ^a  

^a Klinik für Urologie des Diakonissenkrankenhauses Flensburg   (Germany)

Author keywords

C TRUS ANNA; Innovative imaging; Negative biopsies; Prostate biopsies; Prostate cancer diagnostics; Prostate imaging; TRUS

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

BLOOD; ECHOGRAPHY; HUMAN; LABORATORY DIAGNOSIS; MALE; METHODOLOGY; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROSTATE; PROSTATE TUMOR; RECTUM; REVIEW;

BIOPSY, NEEDLE; FALSE NEGATIVE REACTIONS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECTUM; ULTRASONOGRAPHY;

EID: 80053627203     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-011-0715-y     Document Type: Review

References (34)

1. Potosky AL, Miller BA, Albertson PC, Kramer BS (1995) The role of increasing detection in the rising incidence of prostate cancer. JAMA 273: 548-552.
2. Cooner WH, Mosley BR, Rutherford C, Beard JH, Pond HS, Terry WJ, Igel TC, Kidd DD (1990) Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol 143: 1146-1154.
3. Oesterling JE (1991) Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 145: 907-923.
4. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E (1987) Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. New Engl J Med 317: 909-916.
5. Noldus J, Stamey TA (1996) Histological characteristics of radical prostatectomy specimens in men with a serum prostate specific antigen of 4 ng/ml or less. J Urol 155: 441-443.
6. Rabbani F, Stroumbakis N, Kava BR, Cookson MS, Fair WR (1998) Incidence and clinical significance of false-negative sextant prostate biopsies. J Urol 159(4): 1247-1250.
7. Simon J, Kuefer R, Bartsch G Jr, Volkmer BG, Hautmann RE, Gottfried HW (2008) Intensifying the saturation biopsy technique for detecting prostate cancer after previous negative biopsies: a step in the wrong direction. BJU Int 102(4): 459-462.
8. Ashley RA, Inman BA, Routh JC, Mynderse LA, Gettman MT, Blute ML (2008) Reassessing the diagnostic yield of saturation biopsy of the prostate. Eur Urol 53(5): 976-981.
9. Liss MA, Santos R, Osann K, Lau A, Ahlering TE, Ornstein DK (2010) PCA3 molecular urine assay for prostate cancer: association with pathologic features and impact of collection protocols. World J Urol [Epub ahead of print].
10. Roobol MJ, Schröder FH, van Leenders GL, Hessels D, van den Bergh RC, Wolters T, van Leeuwen PJ (2010) Performance of prostate cancer antigen 3 (PCA3) and prostate-specific antigen in prescreened men: reproducibility and detection characteristics for prostate cancer patients with high PCA3 scores (≥100). Eur Urol 58(6): 893-899 (Epub 2010 Sep 26).
11. Djavan B, Fong YK, Ravery V, Remzi M, Horninger W, Susani M, Kreuzer S, Boccon-Gibod L, Bartsch G, Marberger M (2005) Are repeat biopsies required in men with PSA levels & or = 4 ng/ml? A multiinstitutional prospective European study. Eur Urol 47(1): 38-44.
12. Loch T, Eppelmann U, Lehmann J, Wullich B, Loch A, Stöckle M (2004) Transrectal ultrasound guided biopsy of the prostate: random sextant versus biopsies of sono-morphologically suspicious lesions. World J Urol 22(5): 357-360.
13. Lorenz A, Ermert H, Sommerfeld HJ, Garcia-Schürmann M, Senge T, Philippou S (2000) Ultrasound elastography of the prostate. A new technique for tumor detection. Ultraschall Med 21(1): 8-15.
14. Sommerfeld HJ, Garcia-Schürmann JM, Schewe J, Kühne K, Cubick F, Berges RR, Lorenz A, Pesavento A, Scheipers U, Ermert H, Pannek J, Philippou S, Senge T (2003) [Prostate cancer diagnosis using ultrasound elastography. Introduction of a novel technique and first clinical results]. Urologe A 42(7): 941-945 German. Erratum in: Urologe A 42(7): 945.
15. Eggert T, Khaled W, Wenske S, Ermert H, Noldus J (2008) Impact of elastography in clinical diagnosis of prostate cancer. A comparison of cancer detection between B-mode sonography and elastography-guided 10-core biopsies. Urologe A 47(9): 1212-1217.
16. Salomon G, Köllerman J, Thederan I, Chun FK, Budäus L, Schlomm T, Isbarn H, Heinzer H, Huland H, Graefen M (2008) Evaluation of prostate cancer detection with ultrasound real-time elastography: a comparison with step section pathological analysis after radical prostatectomy. Eur Urol 54(6): 1354-1362.
17. Salomon G, Graefen M, Heinzer H, Huland H, Pallwein L, Aigner F, Frauscher F (2009) The value of real-time elastography in the diagnosis of prostate cancer. Urologe A 48(6): 628-636.
18. Loch T, Gettys T, Cochran JS, Fulgham PF, Bertermann H (1990) Computer-aided image-analysis in transrectal ultrasound of the prostate. World J Urol 8: 150-153.
19. Braeckman J, Autier P, Soviany C, Nir R, Nir D, Michielsen D, Treurnicht K, Jarmulowicz M, Bleiberg H, Govindaraju S, Emberton M (2008) The accuracy of transrectal ultrasonography supplemented with computer-aided ultrasonography for detecting small prostate cancers. BJU Int 102(11): 1560-1565.
20. Loch T, Leuschner I, Genberg C, Weichert-Jacobsen K, Küppers F, Yfantis Y, Evans M, Tsarev V, Stöckle M (1999) Artificial neural network analysis (ANNA) of prostatic transrectal ultrasound. Prostate 39: 198-204.
21. Loch T, Leuschner I, Genberg C, Weichert-Jacobsen K, Küppers F, Retz M, Lehmann J, Yfantis Y, Evans M, Tsarev V, Stöckle M (2000) Weiterentwicklung des Transrektalen Ultraschalls: Artifizielle Neuro-nale Netzwerk-Analyse (ANNA) in der Erkennung und Stadieneinteilung des Prostatakarzinoms. Urologe A 39: 341-347.
22. Zacharias M, Jenderka KV, Heynemann H, Fornara P (2002) Transrectal ultrasound of the prostate. Current status and prospects. Urologe A 41(6): 559-568.
23. Wink M, Frauscher F, Cosgrove D, Chapelon JY, Palwein L, Mitterberger M, Harvey C, Rouvière O, de la Rosette J, Wijkstra H (2008) Contrast-enhanced ultrasound and prostate cancer: a multicentre European research coordination project. Eur Urol 54(5): 982-992.
24. Beyersdorff D, Taupitz M, Winkelmann B, Fischer T, Lenk S, Loening SA, Hamm B (2002) Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging. Radiology 224(3): 701-706.
25. Weinreb JC, Blume JD, Coakley FV, Wheeler TM, Cormack JB, Sotto CK, Cho H, Kawashima A, Tempany-Afdhal CM, Macura KJ, Rosen M, Gerst SR, Kurhanewicz J (2009) Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy-results of ACRIN prospective multi-institutional clinicopathologic study. Radiology 251(1): 122-133.
26. Yamamura J, Salomon G, Buchert R, Hohenstein A, Graessner J, Huland H, Graefen M, Adam G, Wedegaertner U (2011) Magnetic resonance imaging of prostate cancer: diffusion-weighted imaging in comparison with sextant biopsy. J Comput Assist Tomogr 35(2): 223-228.
27. Seitz M, Shukla-Dave A, Bjartell A, Touijer K, Sciarra A, Bastian PJ, Stief C, Hricak H, Graser A (2009) Functional magnetic resonance imaging in prostate cancer. Eur Urol 55(4): 801-814 Epub 2009 Jan 21. Review.
28. Lawrentschuk N, Fleshner N (2009) The role of magnetic resonance imaging intargeting prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels. BJU Int 103(6): 730-733.
29. Loch T (2007) Computerized transrectal ultrasound (C-TRUS) of the prostate: detection of cancer in patients with multiple negative systematic random biopsies. World J Urol 25(4): 375-380.
30. Loch T (2004) Computerized supported transrectal ultrasound (C-TRUS) in the diagnosis of prostate cancer. Urologe A 43(11): 1377-1384.
31. Aigner F, Pallwein L, Mitterberger M, Pinggera GM, Mikuz G, Horninger W, Frauscher F (2009) Contrast-enhanced ultrasonography using cadence-contrast pulse sequencing technology for targeted biopsy of the prostate. BJU Int 103(4): 458-463.
32. Singh H, Canto EI, Shariat SF, Miles BJ, Wheeler TM, Slawin KM (2004) Improved detection of clinically significant, curable prostate cancer with systematic 12-core biopsy. J Urol 171: 1089-1092.
33. Vashi AR, Wojno KJ, Gillespie B, Oesterling JE (1997) Patient age and prostate gland size determine the appropriate number of cores per prostate biopsy. J Urol 157: 365 Abstract 1428.
34. Catalona WJ, Smith DS, Ratliff TL, Basler JW (1993) Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 270: 948-954.